Abstract:Liver cancer is a significant global health challenge, with hepatocellular carcinoma (HCC) being the most prevalent form, characterized by high incidence and mortality rates. Despite advances in targeted therapies and immunotherapies, the prognosis for advanced liver cancer remains poor. This underscores the urgent need for a deeper understanding of the molecular mechanisms underlying HCC to enable early detection and the development of novel therapeutic strategies. Post-translational modifications (PTMs) are crucial regulatory mechanisms in cellular biology, affecting protein functionality, interactions, and localization. These modifications, including phosphorylation, acetylation, methylation, ubiquitination, and glycosylation, occur after protein synthesis and play vital roles in various cellular processes. Recent advances in proteomics and molecular biology have highlighted the complex networks of PTMs, emphasizing their critical role in maintaining cellular homeostasis and disease pathogenesis. Dysregulation of PTMs has been associated with several malignant cellular processes in HCC, such as altered cell proliferation, migration, immune evasion, and metabolic reprogramming, contributing to tumor growth and metastasis. This review aims to provide a comprehensive understanding of the pathological mechanisms and clinical implications of various PTMs in liver cancer. By exploring the multifaceted interactions of PTMs and their impact on liver cancer progression, we highlight the potential of PTMs as biomarkers and therapeutic targets. The significance of this review lies in its potential to inform the development of novel therapeutic approaches and improve prognostic tools for early intervention in the fight against liver cancer.

Regulation of ovarian cancer by protein post-translational modifications

O-GlcNAcylation in ovarian tumorigenesis and its therapeutic implications

Protein post-translational modifications in the regulation of cancer hallmarks

Advances in post-translational modifications of proteins and cancer immunotherapy

The role of protein post-translational modifications in prostate cancer

Role of Post-Translational Modifications in Colorectal Cancer Metastasis

Unconventional protein post-translational modifications: the helmsmen in breast cancer

Protein Post-Translational Modifications: A Key Factor in Colorectal Cancer Resistance Mechanisms.

Protein ubiquitination in ovarian cancer immunotherapy: The progress and therapeutic strategy

The Regulation of Protein Translation and Its Implications for Cancer

Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers

Regulating tumor suppressor genes: post-translational modifications

Regulation of PTEN and Ovarian Cancer Progression by an E3 Ubiquitin Ligase RBCK1.

Protein Posttranslational Modification in Stemness Remodeling and Its Emerging Role as a Novel Therapeutic Target in Gastrointestinal Cancers

Posttranslational modifications in pathogenesis of PCOS

Impact of Posttranslational Modifications in Pancreatic Carcinogenesis and Treatments

PTP1B Promotes the Malignancy of Ovarian Cancer Cells in a JNK-dependent Mechanism.

Post-translational Modifications and Immune Responses in Liver Cancer

New Developments in Molecular Targeted Therapy of Ovarian Cancer.

The Global Research of Protein Post-Translational Modifications in the Cancer Field: A Bibliometric and Visualized Study.

Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications